These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23838158)

  • 1. Risk factors for ovarian hyperstimulation syndrome: relevance of the number of follicles, serum estradiol levels and the number of oocytes collected.
    Ata B; Seyhan A; Polat M; Young Son W; Yarali H; Dahan M
    Hum Reprod; 2013 Sep; 28(9):2595. PubMed ID: 23838158
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose hCG supplementation after GnRH agonist triggering: Don't be too quick on the trigger.
    Bodri D
    Hum Reprod; 2013 Sep; 28(9):2315-7. PubMed ID: 23633554
    [No Abstract]   [Full Text] [Related]  

  • 3. Turn, turn, turn.
    Evers JL
    Hum Reprod; 2013 Sep; 28(9):2313-4. PubMed ID: 23887074
    [No Abstract]   [Full Text] [Related]  

  • 4. Oocyte quality and IVF outcome after coasting to prevent ovarian hyperstimulation syndrome.
    Delvigne A; Kostyla K; Murillo D; Van Hoeck J; Rozenberg S
    Int J Fertil Womens Med; 2003; 48(1):25-31. PubMed ID: 12643517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.
    Humaidan P; Polyzos NP; Alsbjerg B; Erb K; Mikkelsen AL; Elbaek HO; Papanikolaou EG; Andersen CY
    Hum Reprod; 2013 Sep; 28(9):2511-21. PubMed ID: 23753114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting.
    DiLuigi AJ; Engmann L; Schmidt DW; Maier DB; Nulsen JC; Benadiva CA
    Fertil Steril; 2010 Aug; 94(3):1111-4. PubMed ID: 20074722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.
    Seyhan A; Ata B; Polat M; Son WY; Yarali H; Dahan MH
    Hum Reprod; 2013 Sep; 28(9):2522-8. PubMed ID: 23633553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of triggering oocyte maturation with a GnRH agonist in polycystic ovary syndrome: two case reports.
    Honnma H; Hashiba Y; Asada Y; Endo T
    Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):239-40. PubMed ID: 21477915
    [No Abstract]   [Full Text] [Related]  

  • 9. The gonadotropin-releasing hormone antagonist protocol--the protocol of choice for the polycystic ovary syndrome patient undergoing controlled ovarian stimulation.
    Kol S; Homburg R; Alsbjerg B; Humaidan P
    Acta Obstet Gynecol Scand; 2012 Jun; 91(6):643-7. PubMed ID: 22428986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevention of ovarian hyperstimulation syndrome.
    Corbett S; Shmorgun D; Claman P; ;
    J Obstet Gynaecol Can; 2014 Nov; 36(11):1024-1033. PubMed ID: 25574681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
    Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
    Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
    Engmann L; DiLuigi A; Schmidt D; Nulsen J; Maier D; Benadiva C
    Fertil Steril; 2008 Jan; 89(1):84-91. PubMed ID: 17462639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GnRHa to trigger final oocyte maturation: a time to reconsider.
    Youssef M; van der Veen F; van Wely M
    Hum Reprod; 2010 Feb; 25(2):559. PubMed ID: 19955105
    [No Abstract]   [Full Text] [Related]  

  • 15. [Coasting: a response to excessive ovarian stimulation].
    Dechaud H; Anahory T; Aligier N; Arnal F; Humeau C; Hédon B
    Gynecol Obstet Fertil; 2000 Feb; 28(2):115-9. PubMed ID: 10758585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
    Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
    Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the prevention of ovarian hyperstimulation syndrome.
    El Tokhy O; Kopeika J; El-Toukhy T
    Womens Health (Lond); 2016 Sep; 12(5):496-503. PubMed ID: 27543490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GnRH agonist triggering: recent developments.
    Kol S; Humaidan P
    Reprod Biomed Online; 2013 Mar; 26(3):226-30. PubMed ID: 23337420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparisons of different dosages of gonadotropin-releasing hormone (GnRH) antagonist, short-acting form and single, half-dose, long-acting form of GnRH agonist during controlled ovarian hyperstimulation and in vitro fertilization.
    Hsieh YY; Chang CC; Tsai HD
    Taiwan J Obstet Gynecol; 2008 Mar; 47(1):66-74. PubMed ID: 18400585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ovarian hyperstimulation induced by a GnRH agonist. About one case].
    Naifer R; Ajina M; Merdassi G; Bibi M; Ibala S; Saad A
    Gynecol Obstet Fertil; 2005 Dec; 33(12):994-7. PubMed ID: 16330236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.